e-Drug3D

961

ESTROPIPATE


INN
ESTROPIPATE

(has an active metabolite)

cas 481-97-0
CLASS

GENITO
ESTROGENIC

ROUTE (list)

ORAL VAGINAL

ATC code

G03CA07
G03CC04

PK parameters

Solubility

SOLUBLE IN WATER


Target

TARGET ESTROGEN RECEPTOR

DrugCentral

Estrogen receptor UNIPROT P03372 ESR1

Download SDF file [(8R,9S,13S,14S)-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate; piperazine

Formula:
C18H22O5S

Calculated chemical properties:

MW 350.43
NB_atoms 24
XLogP 3.29
PSA 82.875
NB_HD 1
NB_HA 5
fsp3 0.61
Lipinski(0=no;1=yes) 1

FDA
NDA 083220 (label) INN (ESTROPIPATE) OGEN .625 (PFIZER) APPROVAL= AP YEAR= 1977
NDA 084710 (pdf not found) INN (ESTROPIPATE) OGEN (PHARMACIA AND UPJOHN) APPROVAL= AP YEAR= 1977 DISCONTINUED
NDA 089567 (pdf not found) INN (ESTROPIPATE) ORTHO-EST (SUN PHARM INDS INC) APPROVAL= AP YEAR= 1991 DISCONTINUED
NDA 089582 (pdf not found) INN (ESTROPIPATE) ORTHO-EST (SUN PHARM INDS INC) APPROVAL= AP YEAR= 1991 DISCONTINUED
NDA 081213 (pdf not found) INN (ESTROPIPATE) ESTROPIPATE (WATSON LABS) APPROVAL= AP YEAR= 1993 DISCONTINUED
NDA 081214 (pdf not found) INN (ESTROPIPATE) ESTROPIPATE (WATSON LABS) APPROVAL= AP YEAR= 1993 DISCONTINUED
NDA 081215 (pdf not found) INN (ESTROPIPATE) ESTROPIPATE (WATSON LABS TEVA) APPROVAL= AP YEAR= 1993 DISCONTINUED
NDA 081216 (pdf not found) INN (ESTROPIPATE) ESTROPIPATE (WATSON LABS) APPROVAL= AP YEAR= 1993 DISCONTINUED
NDA 040135 (pdf not found) INN (ESTROPIPATE) ESTROPIPATE (BARR) APPROVAL= AP YEAR= 1996 DISCONTINUED
NDA 040296 (pdf not found) INN (ESTROPIPATE) ESTROPIPATE (DURAMED PHARMS BARR) APPROVAL= AP YEAR= 1999 DISCONTINUED
NDA 040359 (pdf not found) INN (ESTROPIPATE) ESTROPIPATE (PHARMOBEDIENT) APPROVAL= AP YEAR= 1999 DISCONTINUED

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL

e-Drug3D

11

ESTRONE

DISCONTINUED


INN
ESTRONE

(is an active metabolite)

cas 53-16-7
CLASS

GENITO
ANTI-MENOPAUSAL AGENTS
ESTROGENS
OSTEOPOROSIS PROPHYLACTIC

ROUTE (list)

INJECTION

NATURAL MOLECULE (link)

ATC code

G03CA07
G03CC04

PK parameters

Tmax 4 HOUR

Solubility

SOLUBLE IN WATER


Target

TARGET ESTROGEN RECEPTOR

PDB
3HM1 (CRYSTAL STRUCTURE OF HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A GLUCOCORTICOID RECEPTOR INTERACTING PROTEIN 1 NR BOX II PEPTIDE AND ESTRONE ((8R,9S,13S,14S)-3-HYDROXY-13-METHYL-7,8,9,11,12,14,15,16-OCTAHYDRO-6H-CYCLOPENTA[A]PHENANTHREN-17-ONE))

Ligand code = J3Z (link to the list of PDB complexes)

Download experimental 3D coordinates of J3Z with added hydrogens

DrugCentral

Estrogen receptor UNIPROT P03372 ESR1

Download SDF file (8R,9S,13S,14S)-3-hydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-one

Formula:
C18H22O2

Calculated chemical properties:

MW 270.36
NB_atoms 20
XLogP 3.82
PSA 39.65
NB_HD 1
NB_HA 2
fsp3 0.61
Lipinski(0=no;1=yes) 1

FDA
NDA 083397 (pdf not found) INN (ESTRONE) ESTRONE (WATSON LABS) APPROVAL= - YEAR= 0 DISCONTINUED
NDA 083488 (pdf not found) INN (ESTRONE) ESTROGENIC SUBSTANCE (WYETH AYERST) APPROVAL= - YEAR= 0 DISCONTINUED
NDA 085237 (pdf not found) INN (ESTRONE) NATURAL ESTROGENIC SUBSTANCE-ESTRONE (WATSON LABS) APPROVAL= - YEAR= 0 DISCONTINUED
NDA 003977 (pdf not found) INN (ESTRONE) THEELIN (PARKEDALE) APPROVAL= AP YEAR= 1941 DISCONTINUED
NDA 085239 (pdf not found) INN (ESTRONE) ESTRONE (DR REDDYS) APPROVAL= AP YEAR= 1979 DISCONTINUED

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL